Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2084-2089

  Bastard, Jean Philippe ^a,b,c,d,e   Maachi, Mustapha ^a,b,c,d,e   Van Nhieu, Jeanne Tran ^a,b,c,d,e   Jardel, Claude ^a,b,c,d,e   Bruckert, Eric ^a,b,c,d,e   Grimaldi, André ^a,b,c,d,e   Robert, Jean Jacques ^a,b,c,d,e   Capeau, Jacqueline ^a,b,c,d,e   Hainque, Bernard ^a,b,c,d,e  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

EID: 0036098188     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8450     Document Type: Article

References (29)

1. Insulin resistance and non insulin-dependent diabetes mellitus: Which horse is pulling the cart?
2. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes
3. Adipose tissue as an endocrine and paracrine organ
4. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
5. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
6. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats
7. Molecular mechanisms of insulin resistance and the role of the adipocyte
8. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
9. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
10. Subcutaneous adipose tissue expression of tumor necrosis factor-α is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects
11. Secretion of tumor necrosis factor-α shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue
12. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
13. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α in vivo
14. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycaemic control in patients with NIDDM
15. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity
16. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
17. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia
18. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
19. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women
20. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
21. Glucose clamp technique: A method for quantifying insulin secretion and resistance
22. Percutaneous adipose tissue biopsy by mini-liposuction for metabolic studies
23. Hexose transport in human adipocytes: Factors influencing the response to insulin and kinetics of methylglucose and glucose transport
24. In vitro insulin resistance of human adipocytes isolated from subjects with non-insulin-dependent diabetes mellitus
25. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies
26. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: Increased IL-6 production by β-adrenergic activation and effects of IL-6 on adipocyte function
27. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion
28. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways
29. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells